DVA commissioned La Trobe University to investigate literature on best practice in in-home domestic assistance programs in order to provide a contemporary evidence base to inform any future policy and program development aimed at improving DVA domestic assistance service offerings to veterans and families.

The Department of Veterans' Affairs (DVA) commissioned Australian Catholic University (ACU) National Centre for Veterans and Families to determine the number and accessibility of suicide prevention and postvention programs for the Australian veteran community. The project aims to enhance DVA's understanding of the number and location of Australian suicide prevention and postvention programs and the future needs of the veteran community regarding suicide prevention and postvention programs.

The Department of Veterans' Affairs commissioned the Australian Institute of Family Studies (AIFS) to identify and synthesise existing research on older veterans, and their families’ experiences and needs in aged care. The project was commissioned to inform any future improvements to the way aged care is delivered to veterans and to identify gaps in understanding of the needs of older veterans and their families in aged care settings.

DVA commissioned Gallipoli Medical Research Foundation (GMRF) to undertake a rolling Rapid Evidence Assessment (REA) of emerging and adjunct treatments for post-traumatic stress disorder (PTSD) and common mental health conditions affecting veterans. The emerging treatments were psychedelic interventions (i.e., ketamine; methylenedioxymethamphetamine, MDMA; lysergic acid diethylamide, LSD; psilocybin; and dimethyltryptamine, DMT, including ayahuasca), medicinal cannabis, d-cycloserine (DCS), stellate ganglion block (SGB), and transcranial magnetic stimulation (TMS, including theta-burst stimulation, TBS). The initial REA was delivered in a tranche of seven individual reports in 2022. Four update reports were contracted at 6-monthly intervals to incorporate the most up-to-date information from newly published studies. The goal of the REA was to provide an evidence base to develop a flexible, yet robust, decision-making process that allows DVA to assess emerging treatments for veterans who have not responded to evidence-based treatments.

DVA commissioned Gallipoli Medical Research Foundation (GMRF) to undertake a rolling Rapid Evidence Assessment (REA) of emerging and adjunct treatments for post-traumatic stress disorder (PTSD) and common mental health conditions affecting veterans. The emerging treatments were psychedelic interventions (i.e., ketamine; methylenedioxymethamphetamine, MDMA; lysergic acid diethylamide, LSD; psilocybin; and dimethyltryptamine, DMT, including ayahuasca), medicinal cannabis, d-cycloserine (DCS), stellate ganglion block (SGB), and transcranial magnetic stimulation (TMS, including theta burst stimulation, TBS). The initial REA was delivered in a tranche of seven individual reports in 2022. Four update reports were contracted at 6-monthly intervals to incorporate the most up-to-date information from newly published studies. The goal of the REA was to provide an evidence base to develop a flexible, yet robust, decision-making process that allows DVA to assess emerging treatments for veterans who have not responded to evidence-based treatments.

DVA commissioned Gallipoli Medical Research Foundation (GMRF) to undertake a rolling Rapid Evidence Assessment (REA) of emerging and adjunct treatments for post-traumatic stress disorder (PTSD) and common mental health conditions affecting veterans. The emerging treatments were psychedelic interventions (i.e., ketamine; methylenedioxymethamphetamine, MDMA; lysergic acid diethylamide, LSD; psilocybin; and dimethyltryptamine, DMT, including ayahuasca), medicinal cannabis, d-cycloserine (DCS), stellate ganglion block (SGB), and transcranial magnetic stimulation (TMS, including theta burst stimulation, TBS). The initial REA was delivered in a tranche of seven individual reports in 2022. Four update reports were contracted at 6-monthly intervals to incorporate the most up-to-date information from newly published studies. The goal of the REA was to provide an evidence base to develop a flexible, yet robust, decision-making process that allows DVA to assess emerging treatments for veterans who have not responded to evidence-based treatments.

DVA commissioned Gallipoli Medical Research Foundation (GMRF) to undertake a rolling Rapid Evidence Assessment (REA) of emerging and adjunct treatments for post-traumatic stress disorder (PTSD) and common mental health conditions affecting veterans. The emerging treatments were psychedelic interventions (i.e., ketamine; methylenedioxymethamphetamine, MDMA; lysergic acid diethylamide, LSD; psilocybin; and dimethyltryptamine, DMT, including ayahuasca), medicinal cannabis, d-cycloserine (DCS), stellate ganglion block (SGB), and transcranial magnetic stimulation (TMS, including theta burst stimulation, TBS). The initial REA was delivered in a tranche of seven individual reports in 2022. Four update reports were contracted at 6-monthly intervals to incorporate the most up-to-date information from newly published studies. The goal of the REA was to provide an evidence base to develop a flexible, yet robust, decision-making process that allows DVA to assess emerging treatments for veterans who have not responded to evidence-based treatments.

The Department of Veterans' Affairs commissioned Ernst & Young to conduct a review of better practice approaches in the evaluation of health and wellbeing programs. The aim of the review was to provide recommendations regarding the existing types of evaluation occurring within health programs across Australia (e.g. process, impact, economic/value for money, fidelity, outcome), including the appropriate use of each type of evaluation. These recommendations help inform how the department can plan for and carry out evaluations to support the wellbeing of veterans and families.

The Department of Veterans' Affairs commissioned the University of Newcastle via its College of Health, Medicine and Wellbeing – Centre for Brain and Mental Health Research, to conduct a Horizon Scan of mental health and wellbeing service delivery, with a specific focus on veterans and families. The objective of the Horizon Scan was to identify trends, threats, opportunities, drivers of change and alternative approaches for the department's Mental Health and Wellbeing Services Division (MHWSD) and the broader mental health, wellbeing and veteran and family support sectors, in order to inform the work of the MHWSD Service Review and Transformation Program.

The Horizon Scan was conducted between April and November 2022, and included consultation with representatives from the veteran community (including families), veteran support organisations, academia, government, and professional experts and organisations.

The focus of this review is the comparison of veteran rehabilitation offerings of the Five Eyes countries to understand where Australia's offerings sit in terms of focus, scope of services and eligibility in relation to comparable schemes.